| Accession Number | 0001193125-26-047535 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 9, 2026 | Exercise/Conversion | 5,809,000 | $0.00 | $0.00 | 5,809,000 | Indirect | By Fairmount Healthcare Fund II L.P. | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Exercise/Conversion | 2,904,000 | $0.00 | $0.00 | 2,904,000 | Indirect | By Fairmount Healthcare Co-Invest V L.P. | View Details | |
Director | Series C Preferred Stock | Derivative | Feb 9, 2026 | Exercise/Conversion | 5,809 | $0.00 | $0.00 | 1,148 | Indirect | By Fairmount Healthcare Fund II L.P. | View Details | |
Director | Series C Preferred Stock | Derivative | Feb 9, 2026 | Exercise/Conversion | 2,904 | $0.00 | $0.00 | 574 | Indirect | By Fairmount Healthcare Co-Invest V L.P. | View Details |